Found: 10
Select item for more details and to access through your institution.
Evaluating the Safety, Tolerability, and Disposition of Trazpiroben, a D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist: Phase I Single‐ and Multiple‐Ascending Dose Studies in Healthy Japanese Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 6, p. 695, doi. 10.1002/cpdd.1057
- By:
- Publication type:
- Article
Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 12, p. 1168, doi. 10.1093/jjco/hyv149
- By:
- Publication type:
- Article
Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1828, doi. 10.1007/s10147-022-02232-7
- By:
- Publication type:
- Article
Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Vonoprazan non‐inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 7, p. 1275, doi. 10.1111/jgh.15837
- By:
- Publication type:
- Article
Brigatinib in Japanese patients with ALK‐positive non‐small‐cell lung cancer: Final results of the phase 2 J‐ALTA trial.
- Published in:
- Cancer Science, 2023, v. 114, n. 9, p. 3698, doi. 10.1111/cas.15888
- By:
- Publication type:
- Article
Effect of TAK-085 on Low-density Lipoprotein Particle Size in Patients with Hypertriglyceridemia: A Double-blind Randomized Clinical Study.
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 6, p. 317, doi. 10.1111/1755-5922.12146
- By:
- Publication type:
- Article
Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results.
- Published in:
- 2021
- By:
- Publication type:
- journal article